Cargando…
The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician’s review
OBJECTIVE: Over the last few decades clinicians have become aware that cognitive impairment might be a major cause of disability, loss of employment and poor quality of life in patients suffering from multiple sclerosis [MS]. The impact of disease modifying therapies [DMTs] on cognition is still a m...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368887/ https://www.ncbi.nlm.nih.gov/pubmed/37503514 http://dx.doi.org/10.3389/fneur.2023.1222574 |